Sign in to view content

Don't Miss Diagnosises

Steven Yeh, MD

Video
Published 2017

Related

Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase 2 Study (NEPTUNE)
Robert C. Wang, MD, FASRS
Annual Meeting Talks
2024
Efficacy of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in the Treatment of Macular Edema in Patients With Chronic Uveitis
Christopher R Henry, MD
Annual Meeting Talks
2022
Post-Hoc Fellow Eye Analyses Support SAKURA Program Findings on Vitreous Haze, Visual Acuity and Macular Edema in Noninfectious Uveitis
Pauline T. Merrill, MD, FASRS
On Demand Cases, Courses, and Papers
2018

Category: Inflammatory and Infectious Diseases

See more